BBL CHROMagar Staph aureus is the latest addition to the BBL CHROMagar media line, which already includes CHROMagar Orientation, CHROMagar Candida and CHROMagar Salmonella. BBL CHROMagar Staph aureus eliminates the need to subculture to a non-selective medium, thereby reducing consumable costs, enhancing workflow and allowing susceptibility results to be reported earlier. In addition, a recent clinical study has shown an increased recovery of 11% with BBL CHROMagar Staph aureus compared to Mannitol Salt agar.1
For more information on BBL CHROMagar Staph aureus, please call 1-800-638-8663, or contact your BD Diagnostic Systems representative.
1. 2003 ASM poster C-324, Lema et al., The Johns Hopkins Medical Institutions, "Comparison of CHROMagar Staph aureus to Conventional Media for the Detection of Methicillin Susceptible and Methicillin Resistant Staphylococcus aureus in Clinical Respiratory Samples"
All trademarks are the property of Becton, Dickinson and Company, except CHROMagar, which is a trademark of Dr. A. Rambach. © 2003 BD.